139 related articles for article (PubMed ID: 11241016)
21. Low molecular weight heparin for prevention of thromboembolic complications in cardioversion--rationale and design of the ACE study (Anticoagulation in Cardioversion using Enoxaparin).
Stellbrink C; Hanrath P; Nixdorff U; Hofmann T; Lehmacher W; Kühle K; Fetsch T; Grewe R; Schmidt-Lucke JA;
Z Kardiol; 2002 Mar; 91(3):249-54. PubMed ID: 12001541
[TBL] [Abstract][Full Text] [Related]
22. Low-molecular-weight heparin in transesophageal echocardiography-guided cardioversion of atrial fibrillation.
Wodlinger AM; Pieper JA
Pharmacotherapy; 2003 Jan; 23(1):57-63. PubMed ID: 12523460
[TBL] [Abstract][Full Text] [Related]
23. [Atrial fibrillation and cardioversion: role of transesophageal echocardiography].
Moreo A; Mauri F
Ital Heart J Suppl; 2005 Dec; 6(12):780-7. PubMed ID: 16444922
[TBL] [Abstract][Full Text] [Related]
24. Economic implications of transesophageal echocardiography-guided cardioversion of atrial fibrillation.
Hlatky M; Go AS
J Am Coll Cardiol; 2004 Apr; 43(7):1225-7. PubMed ID: 15063434
[No Abstract] [Full Text] [Related]
25. Bleeding complications in patients with atrial fibrillation undergoing cardioversion randomized to transesophageal echocardiographically guided and conventional anticoagulation therapies.
Klein AL; Murray RD; Grimm RA; Li J; Apperson-Hansen C; Jasper SE; Goodman-Bizon AS; Lieber EA; Black IW;
Am J Cardiol; 2003 Jul; 92(2):161-5. PubMed ID: 12860217
[TBL] [Abstract][Full Text] [Related]
26. Atrial fibrillation: is there a role for low-molecular-weight heparin?
Camm AJ
Clin Cardiol; 2001 Mar; 24(3 Suppl):I15-9. PubMed ID: 11286310
[TBL] [Abstract][Full Text] [Related]
27. Critical appraisal of transesophageal echocardiography in cardioversion of atrial fibrillation.
Malouf JF; Ammash NM; Chandrasekaran K; Friedman PA; Khandheria BK; Gersh BJ
Am J Med; 2002 Nov; 113(7):587-95. PubMed ID: 12459406
[TBL] [Abstract][Full Text] [Related]
28. Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study. A randomized, controlled trial. Assessment of Cardioversion Using Transesophageal Echocardiography.
Klein AL; Grimm RA; Black IW; Leung DY; Chung MK; Vaughn SE; Murray RD; Miller DP; Arheart KL
Ann Intern Med; 1997 Feb; 126(3):200-9. PubMed ID: 9027270
[TBL] [Abstract][Full Text] [Related]
29. [Low molecular weight heparin and non valvular atrial fibrillation].
Ederhy S; Di Angelantonio E; Meuleman C; Janower S; Boccara F; Cohen A
Arch Mal Coeur Vaiss; 2006 Dec; 99(12):1210-4. PubMed ID: 18942523
[TBL] [Abstract][Full Text] [Related]
30. Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation.
Klein AL; Murray RD; Grimm RA
J Am Coll Cardiol; 2001 Mar; 37(3):691-704. PubMed ID: 11693739
[TBL] [Abstract][Full Text] [Related]
31. [Anticoagulation with low molecular weight heparins within the framework of cardioversion for atrial fibrillation].
Tebbe U
Dtsch Med Wochenschr; 2007 Sep; 132(39):2033-6. PubMed ID: 17882745
[No Abstract] [Full Text] [Related]
32. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study.
Black IW; Fatkin D; Sagar KB; Khandheria BK; Leung DY; Galloway JM; Feneley MP; Walsh WF; Grimm RA; Stollberger C
Circulation; 1994 Jun; 89(6):2509-13. PubMed ID: 8205657
[TBL] [Abstract][Full Text] [Related]
33. Transesophageal echocardiography for early cardioversion of atrial fibrillation.
Kamp O; Verhorst PM; Visser CA
Am J Cardiol; 2000 Aug; 86(4A):46G-50G. PubMed ID: 10997355
[TBL] [Abstract][Full Text] [Related]
34. Use of low-molecular-weight heparin as bridge anticoagulation therapy in patients with atrial fibrillation undergoing transoesophageal echocardiography guided cardioversion.
Murray RD; Deitcher SR; Klein AL
Eur Heart J; 2001 Apr; 22(8):712-3. PubMed ID: 11286529
[No Abstract] [Full Text] [Related]
35. Physician practices regarding anticoagulation and cardioversion of atrial fibrillation.
Schlicht JR; Davis RC; Naqi K; Cooper W; Rao BV
Arch Intern Med; 1996 Feb; 156(3):290-4. PubMed ID: 8572839
[TBL] [Abstract][Full Text] [Related]
36. [Anticoagulation and electrical cardioversion of chronic atrial fibrillation: proposal for an abbreviated protocol].
Antonielli E; Pizzuti A; Gandolfo N; Sclavo M; Tanga M; Riva G; Leonardi G; Bassignana A; Di Leo M
G Ital Cardiol; 1997 Aug; 27(8):803-10. PubMed ID: 9312508
[TBL] [Abstract][Full Text] [Related]
37. SAfety of Fondaparinux in transoesophageal echocardiography-guided Electric cardioversion of Atrial Fibrillation (SAFE-AF) study: a pilot study.
Cohen A; Stellbrink C; Le Heuzey JY; Faber T; Aliot E; Banik N; Kropff S; Omran H;
Arch Cardiovasc Dis; 2015 Feb; 108(2):122-31. PubMed ID: 25684570
[TBL] [Abstract][Full Text] [Related]
38. Use of subcutaneous enoxaparin compared to intravenous heparin and oral phenprocoumon in the setting of cardioversion--the ACE study (Anticoagulation in Cardioversion using Enoxaparin).
Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
Card Electrophysiol Rev; 2003 Dec; 7(4):382-6. PubMed ID: 15071260
[TBL] [Abstract][Full Text] [Related]
39. Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study.
Seidl K; Rameken M; Drögemüller A; Vater M; Brandt A; Schwacke H; Bergmeier C; Zahn R; Senges J
J Am Coll Cardiol; 2002 May; 39(9):1436-42. PubMed ID: 11985904
[TBL] [Abstract][Full Text] [Related]
40. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion.
Roijer A; Eskilsson J; Olsson B
Eur Heart J; 2000 May; 21(10):837-47. PubMed ID: 10781356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
